PTC Therapeutics (PTCT) News Today → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free PTCT Stock Alerts $32.14 +3.57 (+12.50%) (As of 04/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePTC Therapeutics (NASDAQ:PTCT) Trading 6.1% Higher marketbeat.com - April 29 at 1:56 PMPTC Therapeutics (NASDAQ:PTCT) Upgraded at Morgan Stanleymarketbeat.com - April 29 at 8:06 AMIndustry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecastsfinance.yahoo.com - April 28 at 9:39 AMPTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcriptseekingalpha.com - April 27 at 2:33 AMPTC Therapeutics (NASDAQ:PTCT) Shares Gap Up on Strong Earningsamericanbankingnews.com - April 27 at 1:42 AMSector Update: Health Care Stocks Edge Higher Late Afternoonfinance.yahoo.com - April 26 at 4:19 PMPTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...finance.yahoo.com - April 26 at 11:17 AMPTC Therapeutics (NASDAQ:PTCT) Shares Gap Up Following Better-Than-Expected Earningsmarketbeat.com - April 26 at 10:56 AMPTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 10:03 PMPTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Resultsprnewswire.com - April 25 at 4:05 PMPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - April 23 at 4:30 PMInsider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Sells 3,361 Shares of Stockinsidertrades.com - April 23 at 5:08 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of "Reduce" from Brokeragesamericanbankingnews.com - April 23 at 4:26 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Recommendation of "Reduce" by Brokeragesmarketbeat.com - April 23 at 4:26 AMMatthew B. Klein Sells 3,361 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stockmarketbeat.com - April 22 at 6:58 PMPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Acquired by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 21 at 6:39 AMEric Pauwels Sells 787 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stockamericanbankingnews.com - April 21 at 5:50 AMPTC Therapeutics (NASDAQ:PTCT) Shares Gap Down to $24.69americanbankingnews.com - April 21 at 3:08 AMPTC Therapeutics CEO sells shares worth over $19kinvesting.com - April 21 at 12:52 AMInsider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Sells 787 Shares of Stockinsidertrades.com - April 20 at 7:28 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Eric Pauwels Sells 787 Sharesmarketbeat.com - April 19 at 6:45 PMPTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Resultsfinance.yahoo.com - April 11 at 10:17 AMPTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Resultsprnewswire.com - April 11 at 8:00 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Sells $14,922.62 in Stockinsidertrades.com - April 5 at 7:46 AMSolid Biosciences gets FDA rare pediatric disease status for DMD therapymsn.com - April 1 at 10:30 AMVanguard Group Inc. Boosts Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT)marketbeat.com - April 1 at 4:12 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Bought by Assenagon Asset Management S.A.marketbeat.com - March 31 at 4:42 AMPTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMAfinance.yahoo.com - March 28 at 9:46 AMPTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $35.00 at Jefferies Financial Groupmarketbeat.com - March 21 at 8:36 AMPTC Therapeutics (NASDAQ:PTCT) Shares Down 3.7% marketbeat.com - March 20 at 6:48 PMBuy Rating for PTC Therapeutics Bolstered by Positive Regulatory Prospects and Gene Therapy Advancesmarkets.businessinsider.com - March 19 at 7:35 PMPTC Therapeutics Gains After Announcement Of Key Regulatory Updatesmarkets.businessinsider.com - March 19 at 2:35 PMPTC Therapeutics (NASDAQ:PTCT) Trading Up 3.3%marketbeat.com - March 19 at 11:58 AMPTC Therapeutics, Inc.: PTC Therapeutics Provides Key Regulatory Updatesfinanznachrichten.de - March 19 at 9:34 AMPTC Therapeutics Submits BLA To FDA For Upstaza - Quick Factsmarkets.businessinsider.com - March 19 at 9:34 AMPTC Therapeutics Provides Key Regulatory Updatesfinance.yahoo.com - March 19 at 9:34 AMWalleye Capital LLC Has $1.61 Million Stock Position in PTC Therapeutics, Inc. (NASDAQ:PTCT)marketbeat.com - March 19 at 4:21 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Bought by Citigroup Inc.marketbeat.com - March 16 at 5:44 AMPTC Therapeutics (NASDAQ:PTCT) Trading Down 5.9%marketbeat.com - March 14 at 12:47 PMJacobs Levy Equity Management Inc. Buys 104,024 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)marketbeat.com - March 12 at 8:38 AMAdage Capital Partners GP L.L.C. Has $3.36 Million Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT)marketbeat.com - March 11 at 6:42 AMQ2 2024 EPS Estimates for PTC Therapeutics, Inc. Decreased by Analyst (NASDAQ:PTCT)marketbeat.com - March 8 at 6:50 AMSeven Eight Capital LP Purchases Shares of 64,722 PTC Therapeutics, Inc. (NASDAQ:PTCT)marketbeat.com - March 7 at 8:39 AMFY2024 EPS Estimates for PTC Therapeutics, Inc. Lowered by Cantor Fitzgerald (NASDAQ:PTCT)marketbeat.com - March 7 at 7:23 AMPTC Therapeutics: Navigating Challenges and Pursuing Growth Amidst Regulatory Hurdlesmarkets.businessinsider.com - March 7 at 7:10 AMBuy Rating Affirmed for PTC Therapeutics Amid Promising Regulatory Progress and Market Opportunitymarkets.businessinsider.com - March 6 at 5:40 PMPTC Therapeutics (NASDAQ:PTCT) Shares Gap Down on Analyst Downgrademarketbeat.com - March 3 at 1:03 AMPTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 10:28 AMPTC Therapeutics Full Year 2023 Earnings: EPS Misses Expectationsfinance.yahoo.com - March 2 at 10:28 AMCantor Fitzgerald Reiterates "Overweight" Rating for PTC Therapeutics (NASDAQ:PTCT)marketbeat.com - March 1 at 10:49 AM Get PTC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne’s Gift to Stock Investors (Ad)Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too. Watch Insider's Advantage Event Tuesday at 4:00 PM ET PTCT Media Mentions By Week PTCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTCT News Sentiment▼0.990.34▲Average Medical News Sentiment PTCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTCT Articles This Week▼184▲PTCT Articles Average Week Get PTC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRVI News GLPG News NAMS News GERN News KROS News AMPH News RNA News SDGR News AGIO News SNDX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTCT) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
